Article
Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria.
Human molecular genetics - 15 Oct 2005
Schmitt Caroline, Gouya Laurent, Malonova Eva, Lamoril Jérôme, Camadro Jean-Michel, Flamme Magali, Rose Christian, Lyoumi Said, Da Silva Vasco, Boileau Catherine, Grandchamp Bernard, Beaumont Carole, Deybach Jean-Charles, Puy Hervé
Abstract excerpt
Hereditary coproporphyria (HCP), an autosomal dominant acute hepatic porphyria, results from mutations in the gene that encodes coproporphyrinogen III oxidase (CPO). HCP (heterozygous or rarely homozygous) patients present with an acute neurovisceral crisis, sometimes associated with skin lesions. Four patients (two families) have been reported with a clinically distinct variant form of HCP. In such patients, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
